ArticleCrohn's & colitis 3602026

Long-term treatment outcomes of upadacitinib for Crohn's disease: a single-center retrospective study.

Takahiro Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.